You have 9 free searches left this month | for more free features.

DKN-01

Showing 1 - 25 of 882

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Endometrial Cancer Trial in Houston (DKN-01, Pembrolizumab)

Not yet recruiting
  • Endometrial Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Feb 27, 2023

Colorectal Cancer, Colorectal Adenocarcinoma, Colo-rectal Cancer Trial (DKN-01, FOLFIRI, Bevacizumab)

Not yet recruiting
  • Colorectal Cancer
  • +3 more
  • DKN-01
  • +3 more
  • (no location specified)
Jul 28, 2022

Prostate Cancer Trial in United States (DKN-01 300 mg, DKN-01 600 mg, Docetaxel 75 mg/m2)

Terminated
  • Prostate Cancer
  • San Francisco, California
  • +4 more
Jan 30, 2023

Esophageal Tumor, Adenocarcinoma of the Gastroesophageal Junction, GastroEsophageal Cancer Trial in United States (DKN-01)

Available
  • Esophageal Neoplasm
  • +9 more
  • DKN-01
  • Birmingham, Alabama
  • +3 more
Aug 24, 2022

Metastatic Esophageal Cancer, Metastatic Gastric Cancer Trial in Sutton (Atezolizumab)

Recruiting
  • Metastatic Esophageal Cancer
  • Metastatic Gastric Cancer
  • Sutton, Surrey, United Kingdom
    The Royal Marsden NHS Foundation Trust
Jul 12, 2021

Esophageal Tumors, Adenocarcinoma of the Gastroesophageal Junction, Gastroesophageal Cancer Trial in United States (DKN-01,

Completed
  • Esophageal Neoplasms
  • +4 more
  • DKN-01
  • +2 more
  • Los Angeles, California
  • +9 more
Sep 9, 2021

Biliary Tract Cancer Trial in Boston (Nivolumab, DKN-01)

Recruiting
  • Biliary Tract Cancer
  • Boston, Massachusetts
  • +1 more
Jan 24, 2021

Hepatocellular Carcinoma Trial in Germany (DKN-01 300 mg, DKN-01 600 mg, Sorafenib)

Unknown status
  • Hepatocellular Carcinoma
  • DKN-01 300 mg
  • +2 more
  • Cologne, Germany
  • +5 more
Oct 20, 2020

Esophageal Cancer, Biliary Tract Cancer, GastroEsophageal Cancer Trial (DKN-01, Atezolizumab, Paclitaxel)

Withdrawn
  • Esophageal Cancer
  • +3 more
  • DKN-01
  • +2 more
  • (no location specified)
Feb 3, 2020

Carcinoma of Intrahepatic and Extra-hepatic Biliary System, Carcinoma of Gallbladder, Bile Duct Cancer Trial in United States

Completed
  • Carcinoma of Intrahepatic and Extra-hepatic Biliary System
  • +3 more
  • DKN-01
  • +2 more
  • Los Angeles, California
  • +8 more
Sep 6, 2018

Porto-Venous Radiomics in Pancreatic Cancer

Recruiting
  • Pancreatic Cancer
  • Non-Interventional
  • London, United Kingdom
    The Royal Marsden NHS Foundation Trust
Jan 17, 2023

Healthy Trial in Adelaide (TR-01-XRR (1), TR-01-XRR (2), TR-01-XRR (3))

Not yet recruiting
  • Healthy
  • TR-01-XRR (1)
  • +6 more
  • Adelaide, South Australia, Australia
    CMAX Clinical Research
Feb 3, 2023

Outcome of GI Cancer in NCKUH

Completed
  • Collection of Real-world Data in a Single Institute
    • Tainan, Taiwan
    • +1 more
    Jan 17, 2023

    Email Reminders on No-Show Rates for Appointments inUrology

    Recruiting
    • No-Show Patients
    • Reminder Systems
    • E-Mail Reminder
    • Caba, Argentina
      Hospital Italiano de Buenos
    Nov 2, 2023

    COVID-19, Infectious Disease, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in United States (RQ-001, Placebo)

    Recruiting
    • COVID-19
    • +3 more
    • RQ-001
    • Placebo
    • Cullman, Alabama
    • +8 more
    Sep 28, 2023

    Joint Pain Trial in Mumbai, Nashik, Panvel (E-PR-01 (Low dose), E-PR-01 (High Dose), Placebo)

    Not yet recruiting
    • Joint Pain
    • E-PR-01 (Low dose)
    • +2 more
    • Mumbai, Maharashtra, India
    • +3 more
    Apr 24, 2023

    Chronic Pain Trial (ST-01, 1% Lidocaine HCL)

    Not yet recruiting
    • Chronic Pain
    • (no location specified)
    Jan 27, 2023

    Study of AAV5-hFIX in Severe or Moderately Severe Haemophilia B

    Active, not recruiting
    • Hemophilia B
    • AAV5-hFIX
    • Berlin, Germany
    • +5 more
    Jan 17, 2023

    How do Perceptions of Coronavirus Disease Risk Influence Health

    Recruiting
    • Pregnancy Related
      • Vancouver, British Columbia, Canada
      • +1 more
      Jan 9, 2023

      Cancer Patient Perspectives During COVID-19

      Active, not recruiting
      • Breast Cancer
        • Aurora, Colorado
          Colorado Research Center
        Nov 17, 2022

        Adverse Events Trial in United States (Irrisept, Standard of Care)

        Completed
        • Adverse Events
        • Irrisept
        • Standard of Care
        • Tucson, Arizona
        • +16 more
        May 4, 2022

        Relative Dose Intensity of Adjuvant Chemotherapy in Older ER+

        Not yet recruiting
        • Breast Cancer
          • (no location specified)
          Aug 21, 2023

          Telomere Biology Disorders With Bone Marrow Failure Trial in Cincinnati (EXG34217)

          Not yet recruiting
          • Telomere Biology Disorders With Bone Marrow Failure
          • EXG34217
          • Cincinnati, Ohio
            Cincinnati Children's Hospital
          May 18, 2023

          Hernia, Inguinal Trial in Salt Lake City (local anaesthetic injection)

          Recruiting
          • Hernia, Inguinal
          • local anaesthetic injection
          • Salt Lake City, Utah
            Todd Bertoch
          Apr 14, 2023

          LTFU Study of Subjects With Cervical SCI Who Received AST-OPC1

          Active, not recruiting
          • Spinal Cord Injuries
          • Magnetic Resonance Imaging (MRI)
          • Los Angeles, California
          • +5 more
          Aug 2, 2023